SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2026 vs. Q4 2025
How the institutions holding SpringWorks Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 2 | 1 | −1 |
| Shares | 40.0K | 1 | −40.0K (−100.0%) |
| Value | $2.18M | $47 | −$2.18M (−100.0%) |
New holders (0)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
None.
Sold out (1)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| DekaBank Deutsche Girozentrale | 40,000 | $2.18M |